Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lilian N Njagi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Tuberculosis (Edinburgh, Scotland)|May 9, 2024
Attenuated tuberculin skin test responses associated with Mycobacterium intracellulare sputum colonization in an adolescent TB prevalence survey in Western KenyaLilian N Njagi, Grace Kaguthi, Jared O Mecha, et al.
BMC Medical Genomics|January 6, 2024
Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicityLilian N Njagi, Jared O Mecha, Marianne W Mureithi, et al.
Science Advances|January 3, 2024
TBscreen: A passive cough classifier for tuberculosis screening with a controlled datasetManuja Sharma, Videlis Nduba, Lilian N Njagi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western KenyaDickens O Onyango, Jerphason O Mecha, Lilian N Njagi, et al.
Open Forum Infectious Diseases|July 15, 2026
Outcomes of the Three-month Weekly Isoniazid With Rifapentine (3HP) Versus the Six-month Isoniazid Preventive Therapy (6H) Among People Newly Enrolled in HIV Care in Western KenyaDickens O Onyango, Jerphason O Mecha, Lilian N Njagi, et al.
Research Square|November 28, 2024
Household contact antigen-speci<b>fi</b>c TNF and IL-2 T-cell responses and impact of index case Mycobacterium tuberculosis aerosolization and HIV Co-infectionLilian N Njagi, Videlis Nduba, Wilfred Bundi Murithi, et al.
Scientific Reports|January 3, 2025
Association of Mycobacterium tuberculosis aerosolization and HIV coinfection in the index case with T cell responses in household contactsLilian N Njagi, Videlis Nduba, Wilfred Bundi Murithi, et al.
Nature Communications|August 31, 2024
Mycobacterium tuberculosis cough aerosol culture status associates with host characteristics and inflammatory profilesVidelis Nduba, Lilian N Njagi, Wilfred Murithi, et al.
HIV/AIDS (Auckland, N.Z.)|July 11, 2018
Trends, treatment outcomes, and determinants for attrition among adult patients in care at a large tertiary HIV clinic in Nairobi, Kenya: a 2004-2015 retrospective cohort studyJared O Mecha, Elizabeth N Kubo, Lucy W Nganga, et al.
Open Forum Infectious Diseases|March 6, 2025
Pulmonary Tuberculosis Infectiousness of Persons Identified Through Active and Passive Case-finding in a High-burden SettingLilian N Njagi, Khai Hoan Tram, Jerry S Zifodya, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Tuberculosis (Edinburgh, Scotland)|May 9, 2024
Attenuated tuberculin skin test responses associated with Mycobacterium intracellulare sputum colonization in an adolescent TB prevalence survey in Western KenyaLilian N Njagi, Grace Kaguthi, Jared O Mecha, et al.
BMC Medical Genomics|January 6, 2024
Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicityLilian N Njagi, Jared O Mecha, Marianne W Mureithi, et al.
Science Advances|January 3, 2024
TBscreen: A passive cough classifier for tuberculosis screening with a controlled datasetManuja Sharma, Videlis Nduba, Lilian N Njagi, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Outcomes of the three-month weekly isoniazid with rifapentine (3HP) versus the six-month isoniazid preventive therapy (6H) among people newly enrolled in HIV care in western KenyaDickens O Onyango, Jerphason O Mecha, Lilian N Njagi, et al.
Open Forum Infectious Diseases|July 15, 2026
Outcomes of the Three-month Weekly Isoniazid With Rifapentine (3HP) Versus the Six-month Isoniazid Preventive Therapy (6H) Among People Newly Enrolled in HIV Care in Western KenyaDickens O Onyango, Jerphason O Mecha, Lilian N Njagi, et al.
Research Square|November 28, 2024
Household contact antigen-speci<b>fi</b>c TNF and IL-2 T-cell responses and impact of index case Mycobacterium tuberculosis aerosolization and HIV Co-infectionLilian N Njagi, Videlis Nduba, Wilfred Bundi Murithi, et al.
Scientific Reports|January 3, 2025
Association of Mycobacterium tuberculosis aerosolization and HIV coinfection in the index case with T cell responses in household contactsLilian N Njagi, Videlis Nduba, Wilfred Bundi Murithi, et al.
Nature Communications|August 31, 2024
Mycobacterium tuberculosis cough aerosol culture status associates with host characteristics and inflammatory profilesVidelis Nduba, Lilian N Njagi, Wilfred Murithi, et al.
HIV/AIDS (Auckland, N.Z.)|July 11, 2018
Trends, treatment outcomes, and determinants for attrition among adult patients in care at a large tertiary HIV clinic in Nairobi, Kenya: a 2004-2015 retrospective cohort studyJared O Mecha, Elizabeth N Kubo, Lucy W Nganga, et al.
Open Forum Infectious Diseases|March 6, 2025
Pulmonary Tuberculosis Infectiousness of Persons Identified Through Active and Passive Case-finding in a High-burden SettingLilian N Njagi, Khai Hoan Tram, Jerry S Zifodya, et al.
Pageof 2